DBCV5352_CCC2022-iPhone-preview
Annual Cycling Event in California Raises Over $1 Million to Fight Arthritis, Impacting Nearly 60 Million Adults and Hundreds of Thousands of Children in the U.S. The 23rd California Coast Classic Bike Tour presented by Amgen, kicks off Saturday in San Francisco en route to Los Angeles with two hundred cyclists.
AOFAS and the Arthri
AOFAS and the Arthritis Foundation Award Grants to Fuel Ankle Arthritis Research
September 19, 2023 15:00 ET | American Orthopaedic Foot & Ankle Society (AOFAS)
Rosemont, Ill., Sept. 19, 2023 (GLOBE NEWSWIRE) -- The American Orthopaedic Foot & Ankle Society (AOFAS) and the Arthritis Foundation (AF) announced the recipients of the first-ever AF/AOFAS...
Sept Canadiens sur d
Sept Canadiens sur dix craignent d’être atteints d’arthrite un jour, ou de l’être déjà
September 07, 2023 09:04 ET | Arthritis Society Canada
TORONTO, 07 sept. 2023 (GLOBE NEWSWIRE) -- Une nouvelle enquête nationale révèle que sept Canadiens sur dix craignent d’être atteints d’arthrite un jour ou de l’être déjà. Septembre est le Mois de...
images.png
Seven-in-10 Canadians fear getting arthritis, or fear they already have it
September 07, 2023 09:04 ET | Arthritis Society Canada
TORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- A new, national survey finds that seven-in-10 Canadians are worried about getting arthritis, or worried that they already have it. September is Arthritis...
ihl_logo.png
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
July 13, 2023 08:00 ET | Incannex Healthcare
Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain...
logo.png
Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up
April 11, 2023 05:00 ET | Paradigm Biopharmaceuticals
MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Australia’s Paradigm Biopharmaceuticals Ltd (ASX:PAR) says analysis of six-month trial data shows injectable pentosan polysulfate sodium...
factMR-logo.png
The Arthritis Therapeutics Market Is Estimated To Grow 1.5x During By 2027: Fact.MR Analysis
March 06, 2023 14:00 ET | FACT.MR
Rockville , March 06, 2023 (GLOBE NEWSWIRE) -- The global arthritis therapeutics market would expand 1.5 times from 2020 to 2027. Patients in Europe and North America would push demand for...
facts-and-factors.jpg
[Latest] Global Psoriatic Arthritis Market Size/Share Worth USD 22.23 Billion by 2030 at a 11.35% CAGR: Facts & Factors (Industrial Trends, Report, Analysis, Players, Outlook, Forecast, Growth, Value, Segmentation)
February 09, 2023 05:54 ET | Facts & Factors
NEW YORK, USA, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Psoriatic Arthritis Market Size, Share, Growth Analysis Report By Route Of...
AOFAS and the Arthri
AOFAS and the Arthritis Foundation Launch Grants Program to Fuel Ankle Arthritis Research
January 27, 2023 10:13 ET | American Orthopaedic Foot & Ankle Society (AOFAS)
Rosemont, Ill., Jan. 27, 2023 (GLOBE NEWSWIRE) -- The American Orthopaedic Foot & Ankle Society® (AOFAS) and the Arthritis Foundation (AF) announced the opening of the first-ever AF/AOFAS Ankle...
Featured Image for The Center for Regenerative Medicine
The Center for Regenerative Medicine Offers State-of-the-Art Non Surgical Solutions for Arthritic Conditions
January 09, 2023 11:31 ET | The Center for Regenerative Medicine
MIAMI, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The Center for Regenerative Medicine (CRM) is paving the way with state-of-the-art, non-surgical treatments to help patients regain quality of life. In order...